FLT3 and acute myeloid leukemia: To elucidate transcriptional cell states that are primed to resisttreatment with the FLT3 inhibitors quizartinib and midostaurin, we appliedReSisTrace in an FLT3-ITD-mutated AML cell line MOLM-13.